An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

January 30, 2023

Study Completion Date

January 30, 2023

Conditions

Healthy Subject

Interventions

DRUG

Ursodeoxycholic Acid 250 Mg Oral Tablet

Administration of Ursodeoxycholic Acid 250 Mg Oral Tablet or Ursodeoxycholic Acid 100 Mg Oral Tablet

Trial Locations (1)

Kyung Hee University Medical Hospital, Seoul